BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CTCF, P49711, 10664, ENSG00000102974
49 results:

  • 1. Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.
    Ramakrishnan S; Cortes-Gomez E; Athans SR; Attwood KM; Rosario SR; Kim SJ; Mager DE; Isenhart EG; Hu Q; Wang J; Woloszynska A
    Genome Med; 2024 Apr; 16(1):52. PubMed ID: 38566104
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DARDN: A Deep-Learning Approach for ctcf Binding Sequence Classification and Oncogenic Regulatory Feature Discovery.
    Cho HJ; Wang Z; Cong Y; Bekiranov S; Zhang A; Zang C
    Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397134
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DNA methylation modulated genetic variant effect on gene transcriptional regulation.
    Zeng Y; Jain R; Lam M; Ahmed M; Guo H; Xu W; Zhong Y; Wei GH; Xu W; He HH
    Genome Biol; 2023 Dec; 24(1):285. PubMed ID: 38066556
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer.
    Armaos A; Serra F; Núñez-Carpintero I; Seo JH; Baca SC; Gustincich S; Valencia A; Freedman ML; Cirillo D; Giambartolomei C; Tartaglia GG
    Nat Commun; 2023 Dec; 14(1):8084. PubMed ID: 38057321
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combined CRISPRi and proteomics screening reveal a cohesin-ctcf-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
    Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
    Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Associations of ctcf and FOXA1 with androgen and IGF pathways in men with localized prostate cancer.
    Barker R; Biernacka K; Kingshott G; Sewell A; Gwiti P; Martin RM; Lane JA; McGeagh L; Koupparis A; Rowe E; Oxley J; Perks CM; Holly JMP
    Growth Horm IGF Res; 2023; 69-70():101533. PubMed ID: 37086646
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MYC reshapes ctcf-mediated chromatin architecture in prostate cancer.
    Wei Z; Wang S; Xu Y; Wang W; Soares F; Ahmed M; Su P; Wang T; Orouji E; Xu X; Zeng Y; Chen S; Liu X; Jia T; Liu Z; Du L; Wang Y; Chen S; Wang C; He HH; Guo H
    Nat Commun; 2023 Mar; 14(1):1787. PubMed ID: 36997534
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. LncRNA PCGEM1 promotes colorectal cancer cell proliferation and migration in positive feedback loop through PCGEM1/miR-433-3p/ctcf axis.
    Xu W; Wu L; Lu H; Xiang X; Wang F; Li S
    Pathol Res Pract; 2022 Sep; 237():154017. PubMed ID: 35872368
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Novel role of prostate cancer risk variant rs7247241 on PPP1R14A isoform transition through allelic TF binding and CpG methylation.
    Tian Y; Soupir A; Liu Q; Wu L; Huang CC; Park JY; Wang L
    Hum Mol Genet; 2022 May; 31(10):1610-1621. PubMed ID: 34849858
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mechanistic insights into genetic susceptibility to prostate cancer.
    Tian P; Zhong M; Wei GH
    Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.
    Lee CA; Abd-Rabbo D; Reimand J
    Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.
    Ahmed M; Soares F; Xia JH; Yang Y; Li J; Guo H; Su P; Tian Y; Lee HJ; Wang M; Akhtar N; Houlahan KE; Bosch A; Zhou S; Mazrooei P; Hua JT; Chen S; Petricca J; Zeng Y; Davies A; Fraser M; Quigley DA; Feng FY; Boutros PC; Lupien M; Zoubeidi A; Wang L; Walsh MJ; Wang T; Ren S; Wei GH; He HH
    Nat Commun; 2021 Mar; 12(1):1781. PubMed ID: 33741908
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. BRD9 Is a Critical Regulator of Androgen Receptor Signaling and prostate cancer Progression.
    Alpsoy A; Utturkar SM; Carter BC; Dhiman A; Torregrosa-Allen SE; Currie MP; Elzey BD; Dykhuizen EC
    Cancer Res; 2021 Feb; 81(4):820-833. PubMed ID: 33355184
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. eRNAs and Superenhancer lncRNAs Are Functional in Human prostate cancer.
    Zhang X; Pang P; Jiang M; Cao Q; Li H; Xu Y; Li Y; Chen X; Han J
    Dis Markers; 2020; 2020():8847986. PubMed ID: 33029258
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ctcf loss mediates unique DNA hypermethylation landscapes in human cancers.
    Damaschke NA; Gawdzik J; Avilla M; Yang B; Svaren J; Roopra A; Luo JH; Yu YP; Keles S; Jarrard DF
    Clin Epigenetics; 2020 Jun; 12(1):80. PubMed ID: 32503656
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer.
    Ramanand SG; Chen Y; Yuan J; Daescu K; Lambros MB; Houlahan KE; Carreira S; Yuan W; Baek G; Sharp A; Paschalis A; Kanchwala M; Gao Y; Aslam A; Safdar N; Zhan X; Raj GV; Xing C; Boutros PC; de Bono J; Zhang MQ; Mani RS
    J Clin Invest; 2020 Aug; 130(8):3987-4005. PubMed ID: 32343676
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ctcf-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer.
    Xing Z; Li S; Liu Z; Zhang C; Bai Z
    Prostate; 2020 Apr; 80(5):388-398. PubMed ID: 31971633
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MethylToSNP: identifying SNPs in Illumina DNA methylation array data.
    LaBarre BA; Goncearenco A; Petrykowska HM; Jaratlerdsiri W; Bornman MSR; Hayes VM; Elnitski L
    Epigenetics Chromatin; 2019 Dec; 12(1):79. PubMed ID: 31861999
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of CCCTC-binding factor (ctcf) is linked to poor prognosis in prostate cancer.
    Höflmayer D; Steinhoff A; Hube-Magg C; Kluth M; Simon R; Burandt E; Tsourlakis MC; Minner S; Sauter G; Büscheck F; Wilczak W; Steurer S; Huland H; Graefen M; Haese A; Heinzer H; Schlomm T; Jacobsen F; Hinsch A; Poos AM; Oswald M; Rippe K; König R; Schroeder C
    Mol Oncol; 2020 Jan; 14(1):129-138. PubMed ID: 31736271
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Deciphering essential cistromes using genome-wide CRISPR screens.
    Fei T; Li W; Peng J; Xiao T; Chen CH; Wu A; Huang J; Zang C; Liu XS; Brown M
    Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25186-25195. PubMed ID: 31727847
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.